Concepedia

James D. O’Neil

JD

Statistics

Publications

4

Citations

660

H-Index

4

Active since

2000

Affiliations

Wellstat Biologics (United States)(Current)

James D. O’Neil is an author at Wellstat Biologics (United States) specializing in oncolytic virus therapy, pharmacology, and pharmacy.

Publications per year

2000–2007

4

Publications

4

Phase I Trial of Intravenous Administration of PV701, an Oncolytic Virus, in Patients With Advanced Solid Cancers

Andrew L. Pecora, Naiyer A. Rizvi, Gary I. Cohen et al. · Journal of Clinical Oncology · 2002 · 389 citations

, , +9

A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step Desensitization

Scott A. Laurie, John C. Bell, Harold Atkins et al. · Clinical Cancer Research · 2006 · 128 citations · Full text

, , +13

An Optimized Clinical Regimen for the Oncolytic Virus PV701

Sebastién J. Hotte, Robert M. Lorence, Hal W. Hirte et al. · Clinical Cancer Research · 2007 · 114 citations · Full text

, , +15

Phase I and Pharmacologic Study of PN401 and Fluorouracil in Patients With Advanced Solid Malignancies

Manuel Hidalgo, Miguel A. Villalona‐Calero, S. Gail Eckhardt et al. · Journal of Clinical Oncology · 2000 · 29 citations

, , +17

1–4 of 4